VRCA – verrica pharmaceuticals inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

VRCA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/24

08:00 am

vrca

Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway

Low Report

Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway

Report

11/14

05:27 pm

vrca

Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results [Yahoo! Finance]

Medium Report

Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results [Yahoo! Finance]

Report

11/14

04:54 pm

vrca

Verrica Pharmaceuticals Non-GAAP EPS of $0.13, revenue of $14.3M [Seeking Alpha]

Medium Report

Verrica Pharmaceuticals Non-GAAP EPS of $0.13, revenue of $14.3M [Seeking Alpha]

Report

11/14

04:05 pm

vrca

Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results

Medium Report

Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results

Report

11/10

08:40 am

vrca

Verrica Pharmaceuticals Presents New Data on VP-315 from its Phase 2 Clinical Trial in Basal Cell Carcinoma at the 40th Society for Immunotherapy of Cancer Annual Meeting [Yahoo! Finance]

Medium Report

Verrica Pharmaceuticals Presents New Data on VP-315 from its Phase 2 Clinical Trial in Basal Cell Carcinoma at the 40th Society for Immunotherapy of Cancer Annual Meeting [Yahoo! Finance]

Report

11/10

08:00 am

vrca

Verrica Pharmaceuticals Presents New Data on VP-315 from its Phase 2 Clinical Trial in Basal Cell Carcinoma at the 40th Society for Immunotherapy of Cancer Annual Meeting

Medium Report

Verrica Pharmaceuticals Presents New Data on VP-315 from its Phase 2 Clinical Trial in Basal Cell Carcinoma at the 40th Society for Immunotherapy of Cancer Annual Meeting

Report

10/24

11:00 am

vrca

Halper Sadeh LLC Encourages Verrica Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Low Report

Halper Sadeh LLC Encourages Verrica Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Report

10/20

04:05 pm

vrca

Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH® in the European Union

High Report

Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH® in the European Union

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/14/2025

04:05 pm

VRCA

verrica pharmaceuticals inc.

BEAT Report

-5.1%

verrica pharmaceuticals inc.

Report

8/12/2025

04:01 pm

VRCA

verrica pharmaceuticals inc.

BEAT Report

-3.4%

verrica pharmaceuticals inc.

Report

5/13/2025

04:05 pm

VRCA

verrica pharmaceuticals inc.

BEAT Report

-2.7%

verrica pharmaceuticals inc.

Report

3/11/2025

04:05 pm

VRCA

verrica pharmaceuticals inc.

BEAT Report

-7.6%

verrica pharmaceuticals inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

Date

Time

Symbol

Headline

Impact

12/3

03:20 pm

vrca

Form SCHEDULE 13G Verrica Pharmaceuticals Filed by: Affinity Asset Advisors, LLC

Low Report

Form SCHEDULE 13G Verrica Pharmaceuticals Filed by: Affinity Asset Advisors, LLC

Report

11/28

05:11 pm

vrca

Form SCHEDULE 13D/A Verrica Pharmaceuticals Filed by: Manning Paul B

High Report

Form SCHEDULE 13D/A Verrica Pharmaceuticals Filed by: Manning Paul B

Report

11/25

07:00 pm

vrca

Form 4 Verrica Pharmaceuticals For: Nov 25 Filed by: Manning Paul B

High Report

Form 4 Verrica Pharmaceuticals For: Nov 25 Filed by: Manning Paul B

Report

11/25

07:00 pm

vrca

Form 4 Verrica Pharmaceuticals For: Nov 25 Filed by: Rieger Jayson

High Report

Form 4 Verrica Pharmaceuticals For: Nov 25 Filed by: Rieger Jayson

Report

11/25

07:00 pm

vrca

Form 4 Verrica Pharmaceuticals For: Nov 25 Filed by: Rosenberg Noah L.

High Report

Form 4 Verrica Pharmaceuticals For: Nov 25 Filed by: Rosenberg Noah L.

Report

11/25

07:00 pm

vrca

Form 4 Verrica Pharmaceuticals For: Nov 25 Filed by: Kirby John J.

High Report

Form 4 Verrica Pharmaceuticals For: Nov 25 Filed by: Kirby John J.

Report

11/25

07:00 pm

vrca

Form 4 Verrica Pharmaceuticals For: Nov 25 Filed by: Zawitz David

High Report

Form 4 Verrica Pharmaceuticals For: Nov 25 Filed by: Zawitz David

Report

11/24

04:15 pm

vrca

Form SCHEDULE 13D Verrica Pharmaceuticals Filed by: Caligan Partners LP

Medium Report

Form SCHEDULE 13D Verrica Pharmaceuticals Filed by: Caligan Partners LP

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.